Skip to content
← Full study record

NCT00851253 · FLOW

Participant flow

Stereotactic Radiosurgery in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer · Source last updated 2018-01-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Radiation: CyberKnife Stereotactic Radiosurgery boost (2 fractionated doses) beginning 4-8 weeks after completion of standard therapy. stereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses
    id
    FG000
    title
    Group 1 (CK SRS Boost Therapy)
  2. description
    Radiation : CyberKnife® stereotactic radiosurgery salvage therapy (5 fractions) 3 times weekly. stereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses
    id
    FG001
    title
    Group 2 (CK SRS Salvage Therapy)
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Disease Progression
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        10
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        10
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
One subject that was enrolled onto the Boost Arm was withdrawn prior to undergoing cyberknife therapy due to disease progression.
recruitment Details
Participants were recruited from within the investigators clinic practice between February 2009 and August 2013
Complete source fields
groups
  1. description
    Radiation: CyberKnife Stereotactic Radiosurgery boost (2 fractionated doses) beginning 4-8 weeks after completion of standard therapy. stereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses
    id
    FG000
    title
    Group 1 (CK SRS Boost Therapy)
  2. description
    Radiation : CyberKnife® stereotactic radiosurgery salvage therapy (5 fractions) 3 times weekly. stereotactic radiosurgery: Given in 2 fractionated doses or 5 fractionated doses
    id
    FG001
    title
    Group 2 (CK SRS Salvage Therapy)
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      Disease Progression
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        10
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        10
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
One subject that was enrolled onto the Boost Arm was withdrawn prior to undergoing cyberknife therapy due to disease progression.
recruitment Details
Participants were recruited from within the investigators clinic practice between February 2009 and August 2013

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice